Reduced incidence of neonatal early‐onset group B streptococcal infection after promulgation of guidelines for risk‐based intrapartum antibiotic prophylaxis in Sweden: analysis of a national population‐based cohort

Introduction This study aimed to investigate the incidence of neonatal early‐onset group B streptococcal (GBS) infection in Sweden after promulgation of guidelines (2008) for risk factor‐based intrapartum antibiotic prophylaxis, and evaluate the presence of risk factors and obstetric management in m...

Full description

Saved in:
Bibliographic Details
Published inActa obstetricia et gynecologica Scandinavica Vol. 96; no. 12; pp. 1475 - 1483
Main Authors Håkansson, Stellan, Lilja, Maria, Jacobsson, Bo, Källén, Karin
Format Journal Article
LanguageEnglish
Published United States John Wiley & Sons, Inc 01.12.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Introduction This study aimed to investigate the incidence of neonatal early‐onset group B streptococcal (GBS) infection in Sweden after promulgation of guidelines (2008) for risk factor‐based intrapartum antibiotic prophylaxis, and evaluate the presence of risk factors and obstetric management in mothers. Material and methods National registers were searched for infants with early‐onset GBS infection during 2006–2011. Medical records of cases and case mothers were ed. Verified cases of sepsis/meningitis and cases with clinical sepsis/pneumonia were documented, as well as risk factors in case mothers and timeliness of intrapartum antibiotic prophylaxis administration. Results There were 227 cases with verified infection, with an incidence of 0.34‰ of live births during the whole period. There was a significant decrease after promulgation of guidelines, from 0.40 to 0.30‰ [odds ratio (OR) 0.75, 95% confidence interval (CI) 0.57–0.99]. A significant decrease in the number of cases with clinical GBS sepsis/pneumonia was also observed. In parturients with one or more risk factors, the incidence of any GBS infection was reduced by approximately 50% (OR 0.47, 95% CI 0.35–0.64), although there were many cases where the opportunity for timely administration of intrapartum antibiotic prophylaxis was missed. In infants of mothers without risk factor(s) there was no reduction in early‐onset GBS morbidity. The mortality in verified cases was 4.8% (95% CI 2.1–7.6). Conclusions The introduction of national guidelines for risk‐based intrapartum antibiotic prophylaxis coincided with a significant 50% risk reduction of neonatal early‐onset GBS infection in infants of parturients presenting with one or more risk factors. A stricter adherence to guidelines could probably have reduced the infant morbidity further.
Bibliography:The authors have stated explicitly that there are no conflicts of interest in connection with this article.
Conflict of interest
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0001-6349
1600-0412
1600-0412
DOI:10.1111/aogs.13211